NEXT Financial Group, Inc - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 37 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$0110.0%0.00%
Q3 2016$0110.0%0.00%
Q3 2014$0110.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
Steamboat Capital Partners, LLC 817,521$414,0000.37%
Abingworth LLP 396,104$195,0000.19%
BOOTHBAY FUND MANAGEMENT, LLC 60,638$31,0000.01%
EAGLE GLOBAL ADVISORS LLC 128,520$65,0000.00%
PANAGORA ASSET MANAGEMENT INC 949,438$481,0000.00%
Renaissance Technologies 908,100$460,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$23,0000.00%
DEUTSCHE BANK AG\ 5$00.00%
CITIGROUP INC 10,376$5,0000.00%
GOLDMAN SACHS GROUP INC 20,037$10,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders